ArticleDrug design, development and therapy2022
Erratum: Switching from a Non-Protease Inhibitor-Based Regimen to the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice [Corrigendum].
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.